Quick-Med Technologies, Inc. (QMDT) Signs New Agreement with Industry Giant BASF

QualityStocks would like to highlight Quick-Med Technologies, Inc. (OTCQB: QMDT), a life sciences company that is developing innovative technologies for the consumer and healthcare markets. In addition to MultiStat, the company’s proprietary family of compounds for anti-aging skin care, Quick-Med is developing advanced antimicrobial technologies for infection prevention and control.

In the company’s news Friday,

Quick-Med Technologies reported entry into an exclusive worldwide manufacturing and distribution agreement for MultiStat with BASF Corporation, planned to stretch out over multiple years.

BASF Corp. is a unit of the massive chemical company BASF Group, one of the world’s top producers with an impressive network of logistical connections throughout the sector and global markets. BASF Beauty Care Solutions has considerable pull in the cosmetics/beauty care area, with a wide range of proficiencies in the biology of skin aging and is among the world’s top biotech and drug delivery system providers.

This is a huge opportunity for QMDT to bring the MultiStat technology to consumers worldwide through BASF’s supplier infrastructure and this newest agreement will supersede extant agreements between the two companies, providing a cooperative framework all the way up to the end of 2014.

The MultiStat technology is realized via a series of proprietary compounds (Matrix Metalloproteinase Inhibitors) that leverage the breakthrough potential of what is essentially a brand new frontier in anti-aging skin care. These compounds have proven results in a whole range of applications, making the end product extremely attractive for ameliorating the appearance of fine lines and wrinkles associated with skin aging or skin damage associated with getting too much sun.

Specifically, the agreement focus on and covers the compound Ilomastat, which has seen validation as a treatment for maintaining the appearance of young and healthy skin in some 250 or more research studies and published academic work.

CEO of QMDT, J. Ladd Greeno, underscored the value of the new Noctafix ingredient that supercharges “MultiStat’s exciting anti-aging potential”. Noctafix has been shown to offer visible benefits in a consumer perception study that looked at a pool of 49 female panelists, including both smokers and non-smokers. The data showed that skin appeared noticeably healthier and more vibrant as therapy was prolonged, offering statistically validated improvements in the appearance of skin at four, eight and 12 weeks.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.